BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36338983)

  • 21. Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinoma.
    Zheng A; Bai J; Ha Y; Yu Y; Fan Y; Liang M; Lu Y; Shen Z; Luo B; Jie W
    BMC Cancer; 2023 Feb; 23(1):135. PubMed ID: 36759775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical significance of nonerythrocytic spectrin Beta 1 (SPTBN1) in human kidney renal clear cell carcinoma and uveal melanoma: a study based on Pan-Cancer Analysis.
    Tang W; Shao Q; He Z; Zhang X; Li X; Wu R
    BMC Cancer; 2023 Apr; 23(1):303. PubMed ID: 37013511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Upregulation of matrix metalloproteinase 14 (MMP14) is associated with poor prognosis in renal clear cell carcinoma-a bioinformatics analysis.
    Zhao YW; Ma W; Jiang F; Xie Y; Tang L
    Transl Androl Urol; 2022 Nov; 11(11):1523-1534. PubMed ID: 36507474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated CDC45 Expression Predicts Poorer Overall Survival Prognoses and Worse Immune Responses for Kidney Renal Clear Cell Carcinoma via Single-Cell and Bulk RNA-Sequencing.
    Zhang X; Zhou J; Wang Y; Wang X; Zhu B; Xing Q
    Biochem Genet; 2023 Aug; ():. PubMed ID: 37642814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioinformatic analyses reveal the prognostic significance and potential role of ankyrin 3 (ANK3) in kidney renal clear cell carcinoma.
    Somsuan K; Aluksanasuwan S
    Genomics Inform; 2023 Jun; 21(2):e22. PubMed ID: 37423640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NCF1/2/4 Are Prognostic Biomarkers Related to the Immune Infiltration of Kidney Renal Clear Cell Carcinoma.
    Chen Y; He F; Wang R; Yao M; Li Y; Guo D; He S
    Biomed Res Int; 2021; 2021():5954036. PubMed ID: 34708124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ASPM Is a Prognostic Biomarker and Correlates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma and Liver Hepatocellular Carcinoma.
    Deng T; Liu Y; Zhuang J; Tang Y; Huo Q
    Front Oncol; 2022; 12():632042. PubMed ID: 35515103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic biomarker NEIL3 and its association with immune infiltration in renal clear cell carcinoma.
    Sun X; Liu P
    Front Oncol; 2023; 13():1073941. PubMed ID: 36816967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LAMTOR3 is a prognostic biomarker in kidney renal clear cell carcinoma.
    Gong Y; Lv Y; Xu F; Xiu Y; Lu Y; Liu Z; Deng L
    J Clin Lab Anal; 2022 Sep; 36(9):e24648. PubMed ID: 36082464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2J2 Is a Diagnostic and Prognostic Biomarker Associated with Immune Infiltration in Kidney Renal Clear Cell Carcinoma.
    Zou X; Mo Z
    Biomed Res Int; 2021; 2021():3771866. PubMed ID: 34258261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression profile and prognostic values of GATA family members in kidney renal clear cell carcinoma.
    Yang X; Mei C; Nie H; Zhou J; Ou C; He X
    Aging (Albany NY); 2023 Mar; 15(6):2170-2188. PubMed ID: 36961416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.
    Song J; Yang R; Wei R; Du Y; He P; Liu X
    Mol Med; 2022 May; 28(1):47. PubMed ID: 35508972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of RARRES1 with ICAM1 modulates macrophages to suppress the progression of kidney renal clear cell carcinoma.
    Geng X; Chi K; Liu C; Fu Z; Wang X; Meng L; Wang H; Cai G; Chen X; Hong Q
    Front Immunol; 2022; 13():982045. PubMed ID: 36353618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and verification of MMP family members as potential biomarkers in kidney clear cell renal carcinoma.
    Zhao T; Li X; Li M; Jamil M; Zhang J
    Am J Cancer Res; 2023; 13(9):3941-3962. PubMed ID: 37818055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrated bioinformatic analysis and cell line experiments reveal the significant role of the novel immune checkpoint TIGIT in kidney renal clear cell carcinoma.
    Xia QD; Li B; Sun JX; Liu CQ; Xu JZ; An Y; Xu MY; Zhang SH; Zhong XY; Zeng N; Ma SY; He HD; Zhang YC; Guan W; Li H; Wang SG
    Front Oncol; 2023; 13():1096341. PubMed ID: 37035135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis.
    Lei P; Zhang M; Li Y; Wang Z
    Front Genet; 2023; 14():996362. PubMed ID: 36999057
    [No Abstract]   [Full Text] [Related]  

  • 38. Comprehensive analysis of the expression, prognosis and biological significance of FSCN family in clear cell renal cell carcinoma.
    Lin Y; Chen R; Jiang M; Hu B; Zheng P; Chen G
    Oncol Lett; 2023 Sep; 26(3):379. PubMed ID: 37559574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An
    Fu S; Gong B; Ding Y; Zhuang C; Chen Q; Wang S; Li Z; Ma M; Liu Y; Zhang Z; Sun T
    Comb Chem High Throughput Screen; 2022; 25(13):2278-2294. PubMed ID: 35293292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive Analysis Reveals Deoxyribonuclease 1 as a Potential Prognostic and Diagnostic Biomarker in Human Cancers.
    Eletr LF; Ibnouf SH; Salih TA; Ibrahim HI; Mustafa MI; Alhashmi NA; Alfaki M
    Cureus; 2024 Mar; 16(3):e56171. PubMed ID: 38618458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.